Browse result page of CancerPDF Database
Please click on CancerPDF_ID for detailed information about peptide.
| CancerPDF_ID | Peptide seq | Protein Name | Fluid | Mass/Z | Profiling Technique | Cancer Type | Expression Regulation | PUBMED ID |
|---|---|---|---|---|---|---|---|---|
| CancerPDF_ID3270 | NA | NA | Serum | 4213.4 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3271 | NA | NA | Serum | 7772.1 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3272 | NA | NA | Serum | 9297.8 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3273 | NA | NA | Serum | 5341 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3274 | NA | NA | Serum | 5909.2 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3275 | NA | NA | Serum | 6636 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3276 | NA | NA | Serum | 4647.8 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3277 | NA | NA | Serum | 4057.2 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3278 | NA | NA | Serum | 3243.9 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3279 | NA | NA | Serum | 3959 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3280 | NA | NA | Serum | 4967.9 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3281 | NA | NA | Serum | 3772.6 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3282 | NA | NA | Serum | 2757.3 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3283 | NA | NA | Serum | 8610.9 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3284 | NA | NA | Serum | 8937.3 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3285 | NA | NA | Serum | 4478.8 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3286 | NA | NA | Serum | 2662.9 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3287 | NA | NA | Serum | 1547.6 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3288 | NA | NA | Serum | 5007.8 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3289 | NA | NA | Serum | 2381.1 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3290 | NA | NA | Serum | 3510.1 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3291 | NA | NA | Serum | 6437.3 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3292 | NA | NA | Serum | 2356.4 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3293 | NA | NA | Serum | 2025.7 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3294 | NA | NA | Serum | 8135.7 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3295 | NA | NA | Serum | 2116.6 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3296 | NA | NA | Serum | 1946.9 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3297 | NA | NA | Serum | 1467.7 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3298 | NA | NA | Serum | 2935.4 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3299 | NA | NA | Serum | 1450.7 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3300 | NA | NA | Serum | 1016.7 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3301 | NA | NA | Serum | 2212.2 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3302 | NA | NA | Serum | 1898.9 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3303 | NA | NA | Serum | 3194.8 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3304 | NA | NA | Serum | 1704.5 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3305 | NA | NA | Serum | 992.2 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3306 | NA | NA | Serum | 2084.5 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3307 | NA | NA | Serum | 9724.2 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3308 | NA | NA | Serum | 5583.3 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3309 | NA | NA | Serum | 4285.7 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3310 | NA | NA | Serum | 2993.5 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3311 | NA | NA | Serum | 2606 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3312 | NA | NA | Serum | 2274.3 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3313 | NA | NA | Serum | 740.9 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3314 | NA | NA | Serum | 2512.8 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3315 | NA | NA | Serum | 4759.2 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3316 | NA | NA | Serum | 3527 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3317 | NA | NA | Serum | 1742.6 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3318 | NA | NA | Serum | 3161.7 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3319 | NA | NA | Serum | 3886.1 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3320 | NA | NA | Serum | 6385.4 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3321 | NA | NA | Serum | 1262.6 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3322 | NA | NA | Serum | 853.1 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3323 | NA | NA | Serum | 1790 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3324 | NA | NA | Serum | 6810 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3325 | NA | NA | Serum | 7476.7 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3326 | NA | NA | Serum | 905.9 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3327 | NA | NA | Serum | 1041.2 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3328 | NA | NA | Serum | 2191.2 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3329 | NA | NA | Serum | 1618.2 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3330 | NA | NA | Serum | 870.1 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3331 | NA | NA | Serum | 2871.2 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3332 | NA | NA | Serum | 3266.5 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3333 | NA | NA | Serum | 6231.3 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3334 | NA | NA | Serum | 1278.4 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3335 | NA | NA | Serum | 3616.4 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
| CancerPDF_ID3336 | NA | NA | Serum | 1115.1 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |